Travis Mickle
Vorsitzender bei KemPharm Denmark A/S
Vermögen: 254 110 $ am 30.04.2024
Profil
Travis C.
Mickle was the founder of Zevra Therapeutics, Inc. founded in 2006, where he held the title of President & Director in 2023.
Currently, he is the Chairman at KemPharm Denmark A.
In the past, he worked as the Director-Drug Discovery & Chemical Development at New River Pharmaceuticals, Inc. from 2003 to 2005.
Dr. Mickle received his undergraduate degree from Simpson College in 1995 and his doctorate degree from the University of Iowa in 2000.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0,13% | 22.03.2024 | 56 219 ( 0,13% ) | 254 110 $ | 30.04.2024 |
Aktive Positionen von Travis Mickle
| Unternehmen | Position | Beginn |
|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Vorsitzender | 13.05.2022 |
Ehemalige bekannte Positionen von Travis Mickle
| Unternehmen | Position | Ende |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Vorstandsvorsitzender | 25.04.2023 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01.10.2005 |
Ausbildung von Travis Mickle
| University of Iowa | Doctorate Degree |
| Simpson College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |
